Prognostic role of distant disease-free interval from completion of adjuvant trastuzumab in HER2-positive early breast cancer: Analysis from the ALTTO (BIG 2-06) trial

Matteo Lambertini, Dominique Agbor-Tarh, Otto Metzger-Filho, Noam F. Ponde, Francesca Poggio, Florentine S. Hilbers, Larissa A. Korde, Saranya Chumsri, Olena Werner, Lucia Del Mastro, Rafael Caparica, Volker Moebus, Alvaro Moreno-Aspitia, Martine J. Piccart, Evandro De Azambuja

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Prognostic role of distant disease-free interval from completion of adjuvant trastuzumab in HER2-positive early breast cancer: Analysis from the ALTTO (BIG 2-06) trial'. Together they form a unique fingerprint.

Medicine & Life Sciences